NCT04298112View on ClinicalTrials.gov

PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2023

Conditions
Prostatic Neoplasms
Interventions
DIAGNOSTIC_TEST

PSMA PET/CT

Whole-body PET/CT (contrast enhanced CT or low-dose CT); from vertex to thighs.

DIAGNOSTIC_TEST

PSMA PET/MR

Pelvic PET/MR in addition to targeted PET/MR according to other findings from the PET/CT (e.g. columna)

Trial Locations (3)

Unknown

Haukeland University Hospital, Bergen

University Hospital of North Norway, Tromsø

St Olavs Hospital, Trondheim

All Listed Sponsors
collaborator

Haukeland University Hospital

OTHER

collaborator

University Hospital of North Norway

OTHER

collaborator

St. Olavs Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT04298112 - PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment | Biotech Hunter | Biotech Hunter